SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-23-042825
Filing Date
2023-04-07
Accepted
2023-04-06 18:08:26
Documents
1
Group Members
BIRCHVIEW FUND LLCMATTHEW STROBECK

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm2312031d1_sc13g.htm SC 13G/A 70850
  Complete submission text file 0001104659-23-042825.txt   72505
Mailing Address 688 PINE STREET, SUITE D C/O BIRCHVIEW CAPITAL BURLINGTON VT 05401
Business Address 688 PINE STREET, SUITE D C/O BIRCHVIEW CAPITAL BURLINGTON VT 05401 802-923-3826
Birchview Capital, LP (Filed by) CIK: 0001618205 (see all company filings)

IRS No.: 383924650 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 12510 PROSPERITY DRIVE SUITE 370 SILVER SPRING MD 20904
Business Address 12510 PROSPERITY DRIVE SUITE 370 SILVER SPRING MD 20904 240-247-1143
AZIYO BIOLOGICS, INC. (Subject) CIK: 0001708527 (see all company filings)

IRS No.: 474790334 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92213 | Film No.: 23807369
SIC: 2836 Biological Products, (No Diagnostic Substances)